H.R.3536: To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.

About This Bill

Bill Version

Bill Actions

Date Description
Aug. 4, 2017
Referred to the Subcommittee on Health.
July 28, 2017
Referred to the House Committee on Energy and Commerce.
July 28, 2017

Introduced in the House by Peter A. DeFazio (D-Ore.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page